For decades we’ve been leaders in the tobacco industry, but the industry is evolving - and so are we.

There are about 55 million U.S. adult nicotine consumers 21+ today, and more than ever they are seeking smoke-free options that fit their lifestyles. 

Our team of more than 250 scientists, physicians, product developers, engineers, and regulatory experts, share a unified objective - to advance tobacco harm reduction. Despite U.S. smoking rates at historic lows, millions of adults continue to smoke. While the best thing to do is quit, many adults can’t or won’t do so. For them, harm reduction includes providing FDA-regulated smoke-free product choices and accurate information about those products as a complement to prevention and cessation efforts.

For adults who continue to smoke, our strategy is to deliver a compelling portfolio of satisfying, smoke-free products regulated by the Food and Drug Administration across three of the most promising smoke-free product platforms: e-vapor, modern oral nicotine pouches, and heated tobacco products.

The journey for adults who smoke to smoke-free products is complicated, personal, and unique. By providing options they want and deserve, we can advance harm reduction for the millions of adults who smoke.